Skip to results
Modify your search
NARROW
1-20 of 31
Authors: Vinai Gondi
Journal Article
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 911–921, https://doi.org/10.1093/neuonc/noad226
Published: 09 December 2023
Journal Article
BIOM-03. LACK OF CORRELATION OF MR-DETERMINED WHITE MATTER INJURY(WMI)WITH NEUROCOGNITIVE FUNCTION (NCF)6 MONTHS FOLLOWING WBRT+/-HIPPOCAMPAL AVOIDANCE(HA)+MEMANTINE:SECONDARY ANALYSIS OF NRG ONCOLOGY NRGCC001
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v4, https://doi.org/10.1093/neuonc/noad179.0014
Published: 10 November 2023
Journal Article
RADT-01. BASELINE HIPPOCAMPAL VOLUME AS A PREDICTOR OF NEUROCOGNITIVE CHANGES AFTER WBRT OR HA-WBRT: SECONDARY ANALYSIS OF NRG ONCOLOGY CC001
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v48, https://doi.org/10.1093/neuonc/noad179.0190
Published: 10 November 2023
Journal Article
CTIM-18. NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v65, https://doi.org/10.1093/neuonc/noad179.0258
Published: 10 November 2023
Journal Article
CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM)
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii83, https://doi.org/10.1093/neuonc/noac209.314
Published: 14 November 2022
Journal Article
NCOG-03. IMPACT OF THE RATE OF RADIOGRAPHIC RESPONSE (RR) OF BRAIN METASTASES (BM) TO WHOLE BRAIN RADIATION THERAPY (WBRT) ON NEUROCOGNITIVE FUNCTION (NCF) ON NRG-CC001
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii197, https://doi.org/10.1093/neuonc/noac209.756
Published: 14 November 2022
Journal Article
Exposure to radon and heavy particulate pollution and incidence of brain tumors
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 407–417, https://doi.org/10.1093/neuonc/noac163
Published: 28 June 2022
Journal Article
EDITOR'S CHOICE
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Neuro-Oncology, Volume 24, Issue 3, March 2022, Pages 331–357, https://doi.org/10.1093/neuonc/noab262
Published: 21 December 2021
Journal Article
CTIM-12. A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHwt GLIOBLASTOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi51–vi52, https://doi.org/10.1093/neuonc/noab196.204
Published: 12 November 2021
Journal Article
CTNI-47. INTERIM RESULTS OF NCT03011671: A MULTI-INSTITUTIONAL PHASE I STUDY OF ACETAZOLAMIDE WITH TEMOZOLOMIDE IN ADULTS WITH NEWLY DIAGNOSED MGMT-METHYLATED MALIGNANT GLIOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi70, https://doi.org/10.1093/neuonc/noab196.272
Published: 12 November 2021
Journal Article
CTNI-50. NEUROCOGNITIVE FUNCTION (NCF) OF THE PHOTON COHORT IN NRG-BN001
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii53–ii54, https://doi.org/10.1093/neuonc/noaa215.216
Published: 09 November 2020
Journal Article
RTID-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1-10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii193, https://doi.org/10.1093/neuonc/noaa215.807
Published: 09 November 2020
Journal Article
NCOG-04. PRETREATMENT VOLUME OF MR-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS NEUROCOGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT+MEMANTINE FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGYCC001
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii129–ii130, https://doi.org/10.1093/neuonc/noaa215.543
Published: 09 November 2020
Journal Article
Radiotherapy innovations to optimize brain metastases control
Neuro-Oncology, Volume 22, Issue 12, December 2020, Pages 1715–1717, https://doi.org/10.1093/neuonc/noaa244
Published: 22 October 2020
Journal Article
RBTT-02. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi219, https://doi.org/10.1093/neuonc/noz175.914
Published: 11 November 2019
Journal Article
ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi24–vi25, https://doi.org/10.1093/neuonc/noz175.092
Published: 11 November 2019
Journal Article
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients
Neuro-Oncology, Volume 21, Issue 7, July 2019, Pages 934–943, https://doi.org/10.1093/neuonc/noz070
Published: 17 April 2019
Journal Article
RTHP-18. POST-OPERATIVE RADIOTHERAPY FOR PATIENTS WITH FUNCTIONING AND NON-FUNCTIONING PITUITARY ADENOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 7551 CASES
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi229, https://doi.org/10.1093/neuonc/noy148.949
Published: 05 November 2018
Journal Article
RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi235, https://doi.org/10.1093/neuonc/noy148.975
Published: 05 November 2018
Journal Article
QOLP-25. QUALITY OF LIFE FOLLOWING RE-IRRADIATION FOR RECURRENT HIGH GRADE GLIOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi220, https://doi.org/10.1093/neuonc/noy148.911
Published: 05 November 2018
